# Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis

> **NCT05910554** · PHASE2 · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Sarcoidosis, Pulmonary

## Interventions

- **DRUG:** Metformin
- **DRUG:** Cellulose

## Key facts

- **NCT ID:** NCT05910554
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12-10
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Many of sarcoidosis patients in this area already taking metformin
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05910554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05910554, "Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05910554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*